Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone for Vocal Cord Paralysis After Thyroidectomy
NCT03553342Phase 3Unknown
- Sponsor
- CHU de Poitiers
- Start
- Sep 2018
- Primary completion
- Sep 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of prednisolone in vocal cord paralysis (VCP), sponsored by CHU de Poitiers. Primary endpoint: Remobilization of vocal cords at 7 days. Status: unknown.
02
Drugs
prednisolone
03
Conditions
vocal cord paralysis (VCP)
Beyond the preview
Go deeper on NCT03553342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03553342.